Denali Therapeutics, Inc. (DNLI)
18.75
-0.91
(-4.63%)
USD |
NASDAQ |
Dec 10, 11:01
Denali Therapeutics EPS Diluted (Quarterly): -0.736 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Masimo Corp. | -1.859 |
| Novavax, Inc. | -1.246 |
| iRhythm Technologies, Inc. | -0.162 |
| AIM ImmunoTech, Inc. | -1.569 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -126.90M |
| Total Expenses (Quarterly) | 126.90M |
| Enterprise Value | 2.080B |
| Earnings Yield | -15.53% |
| Normalized Earnings Yield | -15.53 |